The Safety and Pharmacodynamics of Two Doses of Dabigatran Etexilate in Patients Undergoing Cardiac Catheterization.

Trial Profile

The Safety and Pharmacodynamics of Two Doses of Dabigatran Etexilate in Patients Undergoing Cardiac Catheterization.

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Apr 2014

At a glance

  • Drugs Dabigatran etexilate (Primary) ; Heparin
  • Indications Catheter thrombosis
  • Focus Therapeutic Use
  • Acronyms D-Fine
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 31 Aug 2011 Results presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.
    • 17 Aug 2010 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.
    • 17 Aug 2010 Actual patient number is 53 according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top